Alaunos Therapeutics Inc (TCRT)
2.05
+0.03
(+1.50%)
USD |
NASDAQ |
Oct 31, 16:00
2.00
-0.05
(-2.44%)
After-Hours: 20:00
Alaunos Therapeutics Enterprise Value: 0.7713M for Oct. 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 30, 2024 | 0.7713M |
| October 29, 2024 | 0.8517M |
| October 28, 2024 | 0.8339M |
| October 25, 2024 | 1.012M |
| October 24, 2024 | 1.060M |
| October 23, 2024 | 1.364M |
| October 22, 2024 | 1.172M |
| October 21, 2024 | 0.9958M |
| October 18, 2024 | 1.156M |
| October 17, 2024 | 1.076M |
| October 16, 2024 | 1.401M |
| October 15, 2024 | 1.076M |
| October 14, 2024 | 0.8679M |
| October 11, 2024 | 0.9159M |
| October 10, 2024 | 1.076M |
| October 09, 2024 | 1.060M |
| October 08, 2024 | 1.588M |
| October 07, 2024 | 1.844M |
| October 04, 2024 | 1.748M |
| October 03, 2024 | 1.925M |
| October 02, 2024 | 2.597M |
| October 01, 2024 | 2.669M |
| September 30, 2024 | 2.693M |
| September 27, 2024 | 2.517M |
| September 26, 2024 | 3.206M |
| Date | Value |
|---|---|
| September 25, 2024 | 3.846M |
| September 24, 2024 | 2.901M |
| September 23, 2024 | 2.533M |
| September 20, 2024 | 1.957M |
| September 19, 2024 | 2.053M |
| September 18, 2024 | 2.533M |
| September 17, 2024 | 1.444M |
| September 16, 2024 | 0.9798M |
| September 13, 2024 | 1.268M |
| September 12, 2024 | 1.380M |
| September 11, 2024 | 1.300M |
| September 10, 2024 | 1.380M |
| September 09, 2024 | 1.156M |
| September 06, 2024 | 1.412M |
| September 05, 2024 | 1.588M |
| September 04, 2024 | 1.556M |
| September 03, 2024 | 1.732M |
| August 30, 2024 | 1.684M |
| August 29, 2024 | 1.812M |
| August 28, 2024 | 1.973M |
| August 27, 2024 | 2.021M |
| August 26, 2024 | 2.645M |
| August 23, 2024 | 2.085M |
| August 22, 2024 | 1.716M |
| August 21, 2024 | 1.668M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-1.188M
Minimum
Dec 12 2023
1.087B
Maximum
Feb 08 2021
279.40M
Average
204.84M
Median
Dec 06 2021
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 482.23M |
| Oragenics Inc | 2.027M |
| Cocrystal Pharma Inc | 0.2716M |
| Cara Therapeutics Inc | -40.77M |
| Jaguar Health Inc | 26.35M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.129M |
| Revenue (Quarterly) | 0.004M |
| Total Expenses (Quarterly) | 1.17M |
| EPS Diluted (Quarterly) | -0.71 |
| Profit Margin (Quarterly) | -28.22K% |
| Earnings Yield | -619.9% |
| Normalized Earnings Yield | -436.52 |